U.S. flag An official website of the United States government
  1. Home
  2. News & Events
  3. FDA Meetings, Conferences and Workshops
  4. Public Calendar - Meetings With FDA Officials
  5. Public Calendar: April 5-11, 2020
  1. Public Calendar - Meetings With FDA Officials

Public Calendar: April 5-11, 2020

This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the federal government.

Official Name: Stephen M. Hahn, M.D., Commissioner of Food and Drugs

Event Date: 04/06/2020
Location: Teleconference
Subject: Medical Devices Related to COVID-19
FDA Participant/Group: KEAGAN LENIHAN; JEFFREY SHUREN; ANAND SHAH;
Non FDA Participant/Group: Monica Wilkins, Robert Ford (Abbott);

Event Date: 04/06/2020
Location: Teleconference
Subject: Serology Tests Related to COVID-19
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Members of AdvaMedDX Board, and government

Event Date: 04/07/2020
Location: Teleconference
Subject: Response Efforts Related to COVID-19
FDA Participant/Group: KEAGAN LENIHAN;
Non FDA Participant/Group: David Ricks (Eli Lilly and Company);

Official Name: Amy Abernethy, M.D., Ph.D, Principal Deputy Commissioner

Event Date: 04/07/2020
Location: Virtual
Subject: CBD in Dairy Products
FDA Participant/Group: RACHEL GOMEZ; LOWELL SCHILLER; LAURIE FARMER; JEFFREY FARRAR; PATRICK COURNOYER; KAREN MEISTER; APRIL ALEXANDROW; ERICA WHITE;
Non FDA Participant/Group: Zachary Conlin (NADRO (National Association of Dairy Regulatory Officials));

Official Name: Anand Shah, M.D., Deputy Commissioner for Medical and Scientific Affairs

No Significant Event

Official Name: Anna Abram, Deputy Commissioner for Policy, Legislation, and International Affairs

No Significant Event

Official Name: Jim Sigg, Deputy Commissioner for Operations

No Significant Event

Official Name: Frank Yiannas, Deputy Commissioner for Food Policy and Response

Event Date: 04/07/2020
Location: Virtual Meeting
Subject: Food Safety and Supply Chain Issues in Response to COVID-19
FDA Participant/Group: Several HHS and FDA officials and staff members
Non FDA Participant/Group: Several representatives from the food and beverage industry

Event Date: 04/08/2020
Location: Virtual Meeting
Subject: Salmonella Testing in Foods
FDA Participant/Group: N/A
Non FDA Participant/Group: Several representatives from industry, academia, trade associations, and government

Event Date: 04/09/2020
Location: Virtual Meeting
Subject: Food Safety Issues in Response to COVID-19
FDA Participant/Group: Several FDA officials and staff members
Non FDA Participant/Group: Several representatives from consumer groups

Event Date: 04/10/2020
Location: Virtual Meeting
Subject: Food Safety and Supply Chain Issues in Response to COVID-19
FDA Participant/Group: Several FDA officials and staff members
Non FDA Participant/Group: Several representatives from federal, state, and local governments

Event Date: 04/10/2020
Location: Virtual Meeting
Subject: Food Safety and Supply Chain Issues in Response to COVID-19
FDA Participant/Group: Several FDA officials and staff members
Non FDA Participant/Group: Several representatives from the food and beverage industry

Official Name: Lowell Schiller, Principal Associate Commissioner for Policy

No Significant Event

Official Name: Mark Abdoo, Associate Commissioner for Global Policy and Strategy

No Significant Event

Official Name: Judy McMeekin, Associate Commissioner for Regulatory Affairs

No Significant Event

Official Name: Laura Caliguiri, Associate Commissioner for External Affairs

No Significant Event

Official Name: RADM Denise Hinton, Chief Scientist

No Significant Event

Official Name: Janet Woodcock, M.D., Director, Center for Drug Evaluation and Research

Event Date: 04/06/2020
Location: Virtually
Subject: Longwood Healthcare Leaders Conference: Fireside Chat “Patients at the Center”
FDA Participant/Group: N/A
Non FDA Participant/Group: Andy Plump (Takeda); Jose Baselga (AstraZeneca);

Official Name: Peter Marks, M.D., Ph.D., Director, Center for Biologics Evaluation and Research

No Significant Event

Official Name: Jeffrey Shuren, M.D., J.D., Director, Center for Devices and Radiological Health

No Significant Event

Official Name: Susan T. Mayne, Ph.D., Director, Center for Food Safety and Applied Nutrition

No Significant Event

Official Name: Mitchell R. Zeller, J.D., Director, Center for Tobacco Products

No Significant Event

Official Name: Steven Solomon, Director, Center for Veterinary Medicine

No Significant Event

Official Name: William Slikker, Jr., Ph.D., Director, National Center for Toxicological Research

No Significant Event

Official Name: Stacy Cline Amin, Chief Counsel

No Significant Event